Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a HER2-targeted monoclonal antibody in combination with chemotherapy for advanced colorectal cancer that overexpresses HER2; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• HER2-targeted monoclonal antibody

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED